Orphan Drugs By Global Industry Analysts, Inc., (GIA)

1. Orphan Drugs
Global Industry Analysts, Inc., (GIA)
Report Highlight

2. Orphan Drugs
This report analyzes the worldwide markets for Orphan Drugs in US$ Million. The report provides
separate comprehensive analytics for the US, Europe, Japan, and Rest of World. Annual estimates
and forecasts are provided for the period 2010 through 2018.
Also, a six-year historic analysis is provided for these markets. The report profiles 113 companies
including many key and niche players such as AbbVie Inc., Actelion Pharmaceuticals Ltd., Amgen
Inc., AstraZeneca plc, Bayer HealthCare AG, Biogen Idec Inc., Bristol-Myers Squibb Company,
Boehringer Ingelheim GmbH, Celgene Corporation, CEL-SCI Corporation, Eli Lilly and Company, F.
Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Merck Serono
International S.A., Novartis AG, Pfizer Inc., Recordati S.p.A., Orphan Europe, Sanofi SA, and
Genzyme Corporation. Market data and analytics are derived from primary and secondary
research. Company profiles are primarily based on public domain information including company
URLs

3. Excerpt From Table of Contents
4. CURRENT MARKET TRENDS
Interest of Major Pharmaceutical Firms Signal a Shift in Commercial Dynamics
Select Acquisitions/Mergers in 2010-2011
International Collaboration – The Way Forward
Treating Autism – The Next Big Thing?
Sequencing Technology – The New Research Tool for Orphan Drugs
Innovations in Biotechnology – A Boon for Orphan Drug Research
Aging Gene Linked to Myeloma
Antibody with Potential to Treat Multiple Myeloma
Potential Treatment for Cystic Fibrosis Patients Infected with Mycobacterium abscessus
Genetic Variants to Improve Treatment of Non-small Cell Lung Cancer
5. BREAKTHROUGHS IN ORPHAN DISEASE TREATMENT – A RAY OF HOPE
Telaprevir and Boceprevir for Hepatitis C
Fingolimod for Multiple Sclerosis
Dabigatran and Rivaroxaban to Prevent Strokes in Atrial Fibrillation Patients
Ipilimumab and Vemurafenib for Melanoma
Sipuleucel-T for Prostate Cancer
Crizotinib for Non-Small Cell Lung Cancer
Select List of FDA Approved Breakthroughs (2012)

4. About the Publisher
View More Reports from this Publisher
View This Report
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf
market research. Founded in 1987, the company currently publishes more than
1300 full-scale research reports and analyzes 40,000+ market and technology
trends while monitoring more than 126,000 Companies worldwide. GIA is
recognized today as one of the world's largest and reputed market research
firms serving over 9500 clients in 27 countries.

5. MarketResearch.com provides market research solutions to business professionals
seeking to enhance their business goals. We provide a number of business intelligence
solutions, from individual market research reports from over 700 leading global
publishers, to Knowledge Centers where clients can discover deeper business insight
products into a topic over time. Or perhaps your business needs a much wider view across
multiple industries and topics, if so, our Profound solution allows you to select specific
parts (graphs, tables, charts or sections) from different market research reports.
Our Account Managers have in-depth knowledge of the publishers and the various types
of reports in their respective industries. They give you unbiased and qualitative insights on
which reports will best meet your needs.
If you are interested in expanding your business or growing your market share, contact us
to get a free Consultation to Assess your Market Research Needs. We can help tailor a
solution that suits your unique business goals. One of our Account Managers will get right
back in touch with you.
About Us

6. For More on this Report and Additional Research
Visit MarketResearch.com
Or call
1-800-298-5699